To elucidate the clinical significance of elevated hepatic SHP nuclear localization, we assessed its relationship with the clinical parameters in 38 patients with MASH and 10 control individuals with available SHP nuclear ratio data. Here, NR0B2 is linked to metabolic dysfunction-associated steatohepatitis.